Madison, WI. October 31st, 2016.


Cellular Logistics is pleased to announce the hiring of Rick Soni as CEO . Mr. Soni brings more than 25 years of executive and senior management experience in the pharmaceutical industry to Cellular Logistics. He was President & COO of Rexahn Pharmaceuticals, Director of Commercial Development for Otsuka America, and Product Manager at Novartis. Mr. Soni was directly responsible for bringing billiong-dollar therapeutic products to market for cardiac, CNS and other indications.


“I’m excited to be joining the commercialization work at Cellular Logistics. The Company has a strong team and the lead products have great potential. We have put a clear plan in place and look forward to building this business with cardiac and regenerative medicine therapeutics.”


About the Company: Cellular Logistics is an early stage life science venture based on research at The Wisconsin Institute for Medical Research (WIMR) at the University of Wisconsin-Madison. The Company is commercializing an acellular biomaterial as a stand-alone therapeutic for cardiac and tissue vascularization applications. The material also provides a cell delivery mechanism for regenerative medicine therapeutics.